After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CLDX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Celldex Therapeutics Inc is $1.42B. A total of 0.6 million shares were traded on the day, compared to an average of 946.21K shares.
In the most recent transaction, Marucci Anthony S bought 11,500 shares of CLDX for 26.82 per share on Nov 11 ’24. After the transaction, the PRESIDENT & CEO now owns 40,284 company shares.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CLDX has a high of $47.00 and a low of $14.40.
As of this writing, CLDX has an earnings estimate of -$0.84 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.76 per share and a lower estimate of -$0.95.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CLDX is Buy with a score of 4.73.
